MedPath
HSA Approval

SANKAIJO TABLET

SIN03486P

SANKAIJO TABLET

SANKAIJO TABLET

June 24, 1989

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSATO PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderSATO PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A06AB56

senna glycosides, combinations

Manufacturer Information

SATO PHARMACEUTICAL (SINGAPORE) PTE LTD

SATO PHARMACEUTICAL CO., LTD. HSINCHU FACTORY

Active Ingredients

POWDERED SENNA LEAF

25 mg

Senna leaf

POWDERED RHUBARB

25 mg

Rhubarb

POWDERED ALOE

12.5 mg

Aloe vera leaf

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SANKAIJO TABLET - HSA Approval | MedPath